Appointment of Stephen M. Deitsch as new Chief Financial Officer
04 avr. 2024 11h43 HE | ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners
17 juil. 2023 02h05 HE | ORGANOX LIMITED
OXFORD, United Kingdom, July 17, 2023 (GLOBE NEWSWIRE) -- OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with...
Medical Perfusion Technology Market to Outstrip $962.60 Million by 2027 Growing Sturdy at 4.1% CAGR - COVID-19 Impact and Global Analysis by
22 juin 2021 11h32 HE | The Insight Partners
Pune, India., June 22, 2021 (GLOBE NEWSWIRE) -- Medical Perfusion Technology Market: Key InsightsAccording to our new research study on “Medical Perfusion Technology Market to 2027 – Global Analysis...